EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness

Chenyang Mi, Xuechao Liu, Xiaowen Tang, Guoliang Li

Translational Oncology · 2026-12 · 74 · 103065

DOI: 10.1016/j.tranon.2026.103065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Oncology, 2026-12. Verfasst von Chenyang Mi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, China; Department of Medicinal Chemistry,…. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) poses a distinct modeling challenge. The disease varies by region, histology, metastatic site, and treatment history. It also develops within a gastric niche shaped by acid, mucus, polarity, microbes, and stroma. Patient-derived organoids (PDOs) can preserve tumor-linked epithelial states and support living biobanks. They also enable genotype-phenotype studies and functional testing of therapeutic vulnerabilities. Their clinical value depends on representation, not model complexity alone. The assay must also return clear results within a useful clinical window. This review evaluates GC PDOs as functional companion models for precision oncology rather than stand-alone treatment decision tools. We discuss four barriers that limit clinical readiness. Establishment bias reduces representation of diffuse-type, scirrhous, and signet-ring cell carcinomas. Standard organoid lumens do not reproduce gastric acidity, stratified mucus, or Helicobacter pylori-driven polarity loss. Long-term expansion can select culture-adapted clones and weaken clinical representativeness. PDO drug screening also remains difficult to align with urgent treatment timelines. Fresh-sample assays may shorten turnaround time but reduce scale and depth. We further highlight biological insights gained from GC organoids. These include niche independence, epigenetic dependencies, ARID1A-linked vulnerabilities, and chemotherapy resistance. We propose a readiness framework based on six criteria: tumor authenticity, subtype coverage, niche fidelity, turnaround time, assay standards, and outcome validation. This framework may help define where GC PDOs can support clinical reasoning.

Schlagwörter

Stichwörter der Autor:innen

Clinical readinessDrug sensitivity testingGastric cancerPatient-derived organoidsPrecision oncology

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, China; Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao, 266071, China.
  • Department of General Surgery, The Affiliated Hospital of Qingdao University, Gastrointestinal Tumor Translational Medicine Research Institute of Qingdao University, Qingdao, Shandong, China.
  • Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Electronic address: xwtang1219@qdu.edu.cn.
  • Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, China. Electronic address: liguoliang@qdu.edu.cn.

Förderung

  • Shandong Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Mi, C., Liu, X., Tang, X., & Li, G. (2026). Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness. Translational Oncology, 74, 103065. https://doi.org/10.1016/j.tranon.2026.103065

Vancouver

Mi C, Liu X, Tang X, Li G. Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness. Translational Oncology. 2026;74:103065. doi:10.1016/j.tranon.2026.103065

BibTeX
@article{Mi2026,
  author = {Mi, Chenyang and Liu, Xuechao and Tang, Xiaowen and Li, Guoliang},
  title = {Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness},
  journal = {Translational Oncology},
  year = {2026},
  volume = {74},
  pages = {103065},
  doi = {10.1016/j.tranon.2026.103065}
}
Kostenlos starten →